Sarepta Therapeutics | SRPT - Trade Creditors


Sarepta Therapeutics reported $50.98M in Trade Creditors for its fiscal quarter ending in June of 2026.





Trade Creditors Change Date
Acadia Pharmaceuticals USD 44.57M 32.32M Jun/2026
Agios Pharmaceuticals USD 16.34M 2.6M Jun/2026
Alnylam Pharmaceuticals USD 135.4M 27.38M Sep/2026
Amgen USD 2.86B 16.65B Jun/2026
BioCryst Pharmaceuticals USD 11.46M 501K Jun/2026
Biogen USD 430.3M 26.4M Sep/2026
BioMarin Pharmaceutical USD 913.67M 120.52M Jun/2026
Capricor Therapeutics 3.08M 848.23K Jun/2026
Daiichi Sankyo JPY 539.05B 57.81B Jun/2026
Eli Lilly USD 5.79B 319M Sep/2026
Gilead Sciences USD 934M 260M Sep/2026
Incyte USD 235.37M 1.16B Sep/2026
Insmed USD 84.3M 9.75M Sep/2026
Ionis Pharmaceuticals USD 47.7M 21.67M Jun/2026
Moderna USD 167M 6M Jun/2026
Nektar Therapeutics USD 10.03M 744K Mar/2026
Neurocrine Biosciences USD 691.3M 145.8M Mar/2026
Novavax USD 22.94M 6.84M Jun/2026
Pfizer USD 4.58B 75M Jun/2026
PTC Therapeutics USD 41.59M 1.14M Sep/2026
Regeneron Pharmaceuticals USD 1.14B 19M Sep/2026
Roche Holding CHF 5.54B 237M Jun/2026
Sangamo BioSciences USD 10.74M 7.46M Jun/2025
Sanofi EUR 23.6B 888M Jun/2026
Sarepta Therapeutics USD 50.98M 19.39M Jun/2026
Tectonic Therapeutic USD 2.55M 1.46M Mar/2026
Ultragenyx Pharmaceutical USD 39M 3M Jun/2026
Vertex Pharmaceuticals USD 3.61B 135M Jun/2026